Why the study?
Hypertension is reported in over two-thirds of patients with type 2 diabetes, and digital multicondition platforms seek to assist these patients in managing diabetes and comorbidities.
Does a self-management multicondition digital platform improve blood pressure and glycemic control in patients with diabetes and hypertension?
Does a self-management multicondition digital platform improve blood pressure and glycemic control in patients with diabetes and hypertension?
Use of a multicondition digital therapeutic platform was associated with significant improvements in both systolic blood pressure and blood glucose levels over 6 months in patients with diabetes and hypertension.
No takes yet. Share an insight, caveat, or question.
May support integrated digital self-management of diabetes with hypertension; leaves open need for randomized confirmation.
HERSHCOVITZ et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: